Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1988 Oct 22;297(6655):999–1000. doi: 10.1136/bmj.297.6655.999

Flumazenil: a benzodiazepine antagonist.

J G Whitwam 1
PMCID: PMC1834756  PMID: 2903780

Full text

PDF
1000

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alon E., Baitella L., Hossli G. Double-blind study of the reversal of midazolam-supplemented general anaesthesia with Ro 15-1788. Br J Anaesth. 1987 Apr;59(4):455–458. doi: 10.1093/bja/59.4.455. [DOI] [PubMed] [Google Scholar]
  2. Ashton H. Benzodiazepine withdrawal: an unfinished story. Br Med J (Clin Res Ed) 1984 Apr 14;288(6424):1135–1140. doi: 10.1136/bmj.288.6424.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiolero R. L., Ravussin P., Anderes J. P., Ledermann P., de Tribolet N. The effects of midazolam reversal by RO 15-1788 on cerebral perfusion pressure in patients with severe head injury. Intensive Care Med. 1988;14(3):196–200. doi: 10.1007/BF00717986. [DOI] [PubMed] [Google Scholar]
  4. Cumin R., Bonetti E. P., Scherschlicht R., Haefely W. E. Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines. Experientia. 1982 Jul 15;38(7):833–834. doi: 10.1007/BF01972300. [DOI] [PubMed] [Google Scholar]
  5. Darragh A., Lambe R., Kenny M., Brick I. Tolerance of healthy volunteers to intravenous administration of the benzodiazepine antagonist Ro 15-1788. Eur J Clin Pharmacol. 1983;24(4):569–570. doi: 10.1007/BF00609905. [DOI] [PubMed] [Google Scholar]
  6. Desenclos J. C. Relief food and vitamin C deficiency. Lancet. 1987 Aug 22;2(8556):462–463. doi: 10.1016/s0140-6736(87)91006-3. [DOI] [PubMed] [Google Scholar]
  7. File S. E., Baldwin H. A. Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety. Lancet. 1987 Jul 11;2(8550):106–107. doi: 10.1016/s0140-6736(87)92779-6. [DOI] [PubMed] [Google Scholar]
  8. Flumazenil and benzodiazepine withdrawal. Lancet. 1987 Aug 22;2(8556):463–463. [PubMed] [Google Scholar]
  9. Kirkegaard L., Knudsen L., Jensen S., Kruse A. Benzodiazepine antagonist Ro 15-1788. Antagonism of diazepam sedation in outpatients undergoing gastroscopy. Anaesthesia. 1986 Dec;41(12):1184–1188. doi: 10.1111/j.1365-2044.1986.tb13001.x. [DOI] [PubMed] [Google Scholar]
  10. Kleinberger G., Grimm G., Laggner A., Drume W., Lenz K., Schneeweiss B. Weaning patients from mechanical ventilation by benzodiazepine antagonist Ro15-1788. Lancet. 1985 Aug 3;2(8449):268–269. doi: 10.1016/s0140-6736(85)90309-5. [DOI] [PubMed] [Google Scholar]
  11. Klotz U., Kanto J. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788). Clin Pharmacokinet. 1988 Jan;14(1):1–12. doi: 10.2165/00003088-198814010-00001. [DOI] [PubMed] [Google Scholar]
  12. Klotz U., Ziegler G., Ludwig L., Reimann I. W. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans. J Clin Pharmacol. 1985 Sep;25(6):400–406. doi: 10.1002/j.1552-4604.1985.tb02866.x. [DOI] [PubMed] [Google Scholar]
  13. Klotz U., Ziegler G., Reimann I. W. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol. 1984;27(1):115–117. [PubMed] [Google Scholar]
  14. Lauven P. M., Schwilden H., Stoeckel H., Greenblatt D. J. The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam. Anesthesiology. 1985 Jul;63(1):61–64. doi: 10.1097/00000542-198507000-00009. [DOI] [PubMed] [Google Scholar]
  15. Lugaresi E., Medori R., Montagna P., Baruzzi A., Cortelli P., Lugaresi A., Tinuper P., Zucconi M., Gambetti P. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med. 1986 Oct 16;315(16):997–1003. doi: 10.1056/NEJM198610163151605. [DOI] [PubMed] [Google Scholar]
  16. O'Boyle C., Lambe R., Darragh A., Taffe W., Brick I., Kenny M. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability. Br J Anaesth. 1983 Apr;55(4):349–356. doi: 10.1093/bja/55.4.349. [DOI] [PubMed] [Google Scholar]
  17. Ricou B., Forster A., Brückner A., Chastonay P., Gemperle M. Clinical evaluation of a specific benzodiazepine antagonist (RO 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation. Br J Anaesth. 1986 Sep;58(9):1005–1011. doi: 10.1093/bja/58.9.1005. [DOI] [PubMed] [Google Scholar]
  18. Sage D. J., Close A., Boas R. A. Reversal of midazolam sedation with anexate. Br J Anaesth. 1987 Apr;59(4):459–464. doi: 10.1093/bja/59.4.459. [DOI] [PubMed] [Google Scholar]
  19. Samson Y., Hantraye P., Baron J. C., Soussaline F., Comar D., Mazière M. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. Eur J Pharmacol. 1985 Apr 2;110(2):247–251. doi: 10.1016/0014-2999(85)90218-3. [DOI] [PubMed] [Google Scholar]
  20. Scollo-Lavizzari G. First clinical investigation of the benzodiazepine antagonist Ro 15-1788 in comatose patients. Eur Neurol. 1983;22(1):7–11. doi: 10.1159/000115529. [DOI] [PubMed] [Google Scholar]
  21. Scollo-Lavizzari G., Matthis H. Benzodiazepine antagonist (RO 15-1788) in ethanol intoxication: a pilot study. Eur Neurol. 1985;24(5):352–354. doi: 10.1159/000115824. [DOI] [PubMed] [Google Scholar]
  22. Shinotoh H., Yamasaki T., Inoue O., Itoh T., Suzuki K., Hashimoto K., Tateno Y., Ikehira H. Visualization of specific binding sites of benzodiazepine in human brain. J Nucl Med. 1986 Oct;27(10):1593–1599. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES